Elmiron, which is widely used to treat bladder conditions, has been found to cause eye damage and vision problems in Philadelphia patients. Emerging research indicates that Philadelphia persons who have taken Elmiron (pentosan polysulfate sodium) for fifteen or more years are at significant risk for retinal damage. Additional Elmiron eye damage has been found to increase as the quantity of the drug increases. Hundreds of thousands of patients, including thousands in Philadelphia, who have relied on this drug for the treatment of interstitial cystitis (IC) were never warned of the risk of Elmiron vision loss or eye damage.
Elmiron is a product of Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. Elmiron received FDA approval in 1996 and is the only approved treatment for the interstitial cystitis, a bladder condition that affects a million Americans including many Philadelphia residents, most of them women. Elmiron's patent expired in 2010 but no generics have been developed and Janssen continues to raise the cost for this sought-after drug. Elmiron is the next in a long line of dangerous drugs and faulty medical devices marketed to Philadelphia residents by Johnson & Johnson, which includes Tylenol, Benadryl, Sudafed, Rolaids, Zyrtec, DePuy Hip Systems, pelvic mesh, Risperdal, Power morcellators and hernia mesh. Despite these significant drug problems and the fallout for millions of Americans, J&J's CEO garners annual compensation of over $20 million. Elmiron generates more than $150 million in sales each year on behalf of J&J. Meanwhile, residents of Philadelphia spend $600 or more monthly to purchase this dangerous drug.
Alongside millions of Americans, residents of Philadelphia are now learning that the drug they have relied upon for years to treat one problem was actually causing another: Elmiron vision loss. J&J faces serious questions from Philadelphia consumers and medical personnel as to why the public has never been warned of the risk for eye damage from Elmiron. Critics say J&J knew, or should have known, of this serious Elmiron side effect. Persons and the family members of persons in Philadelphia who suffered from Elmiron vision loss are filing Elmiron eye damage lawsuits against Johnson & Johnson. Filing an Elmiron lawsuit enables Philadelphia consumers to obtain the compensation they deserve for suffering, damage, medical expenses and loss related to Elmiron eye damage in Philadelphia. In addition, filing a Philadelphia Elmiron eye lawsuit claim is the best method for Philadelphia consumers to hold J&J accountable for its unethical business practices.
If you or a loved one in Philadelphia has developed vision loss or eye problems as a result of taking Elmiron, you may have grounds to file a Philadelphia Elmiron eye lawsuit against Janssen Pharmaceuticals, a division of Johnson & Johnson. Elmiron eye lawsuits and vision loss claims allow Philadelphia persons and families harmed by Elmiron eye damage to seek compensation for the medical expenses, pain, loss and suffering that have resulted from this dangerous drug.
Elmiron has been in wide use since 1996, when it was first approved by the FDA to treat interstitial cystitis (IC). A painful bladder condition, IC affects approximately a million Americans, including many Philadelphia residents, most of them women. Elmiron is the only drug approved to treat IC at this time, and consumers and doctors alike in Philadelphia trusted the drug as safe.
Emerging research shows Elmiron eye damage is commonplace among patients who have taken the drug for a number of years. Believed to be toxic to a particular part of the eye tissue, Elmiron causes eye problems in Philadelphia such as blurriness, vision loss, and difficulty reading. Yielding $150 million in annual sales, Elmiron is a highly profitable drug for J&J.
Critics say J&J knew or should have known of the risk for Elmiron eye problems, and had a responsibility to warn Philadelphia consumers. Persons and families harmed by Elmiron vision loss in Philadelphia are filing claims against J&J to recover damages and seek justice.
If you or a member of your family developed vision problems while taking Elmiron in Philadelphia, you may qualify to file an Elmiron eye lawsuit to recover compensation for damages you have suffered as a result of this dangerous drug. Filing a lawsuit is the only way to secure compensation for medical bills, lost time at work, pain, suffering and loss that have resulted from Philadelphia Elmiron vision loss. Our attorneys accept Elmiron eye lawsuits from Philadelphia residents, and offer no-cost, no-obligation Elmiron lawsuit case review for persons in Philadelphia who match this description. To discuss your situation in detail with an attorney and to learn about Elmiron lawsuit time limits in Philadelphia, please complete our online contact form. One of our attorneys handling Elmiron lawsuits for Philadelphia residents will contact you promptly.
Persons harmed by Elmiron eye problems in Philadelphia frequently wonder if filing an Elmiron eye lawsuit will lead to meaningful compensation. Our attorneys offer assurance that Elmiron eye problems lawsuits from Philadelphia will not be class action lawsuits, in which Philadelphia plaintiffs can expect merely a small, symbolic settlement. On the contrary, lawyers handling Elmiron lawsuits believe Philadelphia persons and family members of persons who have developed vision loss or other eye problems from Elmiron may be entitled to significant compensation. Elmiron eye lawsuits from Philadelphia are likely to be consolidated with others around the nation as Multi-District Litigation (MDL), in which each claim will be handled on its own merit and compensation will be determined based on the degree of suffering of each plaintiff.
We will represent all Philadelphia persons involved in an Elmiron eye lawsuit on a contingency basis, meaning our lawyers never charge legal fees unless we win compensation in your case. For a free no-obligation consultation please fill out our short online contact form and one of our Elmiron attorneys for vision loss and eye damage in Philadelphia will contact you to answer any of your questions.
This page contains answers to common Elmiron lawsuit questions that apply to most Philadelphia Elmiron claims for vision loss and eye damage. If you do not find answers here or you would like to discuss your case in detail, please contact our firm. Our Elmiron eye attorneys serving Philadelphia provide free, no obligation case reviews to persons and families harmed by Elmiron eye damage in Philadelphia. Simply contact our firm and one of our experienced lawyers handling Elmiron lawsuit claims for Philadelphia eye problems and vision loss will contact you in the near future to answer your questions, at no charge to you.
The Elmiron vision loss lawyers serving Philadelphia at The Onder Law Firm are national leaders in the area of product liability litigation and have a distinguished track record of success, winning major cases against billion dollar pharmaceutical conglomerates. Our mission is to pursue justice on behalf of American families harmed by negligence and corporate greed.
Our expert Elmiron attorneys serving Philadelphia residents have witnessed the aftereffects of numerous drug recalls, supporting families by winning significant compensation for our clients. Aware of the grave nature of Elmiron lawsuits for eye damage and vision in Philadelphia, this national drug litigation law firm has committed its substantial resources to providing clients in Philadelphia with the best Elmiron lawyer representation available.
Our Elmiron attorneys believe Philadelphia persons and family members of Philadelphia persons who have developed eye problems or vision disturbances may be eligible for real compensation for pain, suffering, medical expenses, and loss by filing a claim against J&J. Elmiron has been shown to be toxic to the pigmented portion of the retina, resulting in vision loss, difficulty reading, sensitivity to darkness, and other eye problems in Philadelphia. Elmiron yields $150 million in annual sales, and critics say Janssen Pharmaceuticals knew or should have known of this serious danger associated with the drug.
Elmiron eye lawyers believe that filing Elmiron lawsuits in Philadelphia is the only effective method to seek compensation for the harm resulting from this dangerous drug. Furthermore, it is an unfortunate fact that the threat of litigation is often the only effective way to pressure a large company to prioritize consumer safety over profits. Our Elmiron lawyers are firmly resolved to obtain for Philadelphia clients the compensation they need and deserve.
Our Elmiron eye damage attorneys serving will provide a free case review to persons who have suffered from vision loss or eye problems from Elmiron in Philadelphia. The Onder Law Firm's Elmiron eye attorneys serving Philadelphia residents provide experienced legal representation without fee unless they collect for their clients.
We will represent all persons involved in a Philadelphia Elmiron lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. Persons or family members of persons who developed eye problems or suffered vision loss from Elmiron in Philadelphia are eligible to receive a free, no-obligation case review from our attorneys. Simply contact our firm through the online contact form or the chat feature and one of our Elmiron eye lawyers serving Philadelphia will contact you promptly to discuss your case.
The Onder Law Firm is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, Truvada, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including Truvada hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation. For more information, visit www.OnderLaw.com or call 1-877-ONDER-LAW.